Clinical Trials Logo

Pelvic Cancer clinical trials

View clinical trials related to Pelvic Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05524454 Completed - Breast Cancer Clinical Trials

Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy

CONFIGURE
Start date: March 20, 2023
Phase: N/A
Study type: Interventional

This is a feasibility study investigating the image quality of a new, high-performance cone beam CT (CBCT) used for on-couch imaging during radiotherapy treatments.

NCT ID: NCT05074082 Completed - Rectal Cancer Clinical Trials

Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy

Start date: July 31, 2021
Phase:
Study type: Observational

Flap reconstruction is utilised increasingly for repair of skin and soft tissue defects following pelvic exenteration. Many methods have been proposed but the outcomes associated with each remain largely unknown and the choice dependant on surgeon preference and patient/ disease characteristics. This review sought to assess the preferred methods for perineal reconstruction following pelvic exenteration by retrospectively assessing the outcomes associated with each at an international, multi-centre level.

NCT ID: NCT05074069 Completed - Pelvic Cancer Clinical Trials

A Review of Functional and Surgical Outcomes of Gynaecological Reconstruction in the Context of Pelvic Exenteration

Start date: July 1, 2021
Phase:
Study type: Observational

Patients with locally advanced pelvic malignancy undergo radical procedures, necessitate organ reconstruction. Little is known about the preferred methods of gynaecological organ reconstruction in the context of pelvic exenteration. This review aims to identify which methods are commonly used and what outcomes are associated with each technique in order to further guide future practice.

NCT ID: NCT04553471 Completed - Sarcoma Clinical Trials

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

Start date: September 22, 2020
Phase: N/A
Study type: Interventional

This is a study evaluating the safety and efficacy of Lattice SBRT for patients with large tumors (≥ 4.5 cm) planning to undergo palliative radiotherapy.

NCT ID: NCT04184154 Completed - Cervical Cancer Clinical Trials

Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy.

Gyn&Co
Start date: April 5, 2017
Phase:
Study type: Observational

Gynecologic cancer treatments (chemoradiotherapy, brachytherapy and surgery) greatly impact patients' sexual quality of life (QoL). Use of the vaginal dilators may reduce vaginal stenosis. Since 2011, our "Gyn and Co LR" patient education program aims to optimize early care of sexual disorders following treatment of cervical and endometrial cancer.

NCT ID: NCT04070950 Completed - Sexual Behavior Clinical Trials

Sexuality of Women With Pelvic Cancer

FECAPSE
Start date: September 1, 2009
Phase:
Study type: Observational

This study aims to study in patients with cancer of the cervix or the body of the uterus, or the ovary between the time of diagnosis and 3 months after the end of the last treatment: the evolution of the relationship of couple, and more particularly of communication (verbal and non-verbal) concerning sexuality, before and during cancer.

NCT ID: NCT03757858 Completed - Cancer Clinical Trials

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Start date: March 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

It is a non-randomized pilot study.The allocation will be determined by patients or their immediate family members who were cooperative with physician's interpretations on the disease progression and updated information of cutting of edge treatment, the financial affordability, availability of treatment plans, possible tolerance or risks etc.The purpose of this study is to investigate the clinical efficacy and toxicity of autologous cellular immunotherapy combined with hyperthermia in abdominal and pelvic malignancies or metastases patients. Furthermore, to characterize response to different regimens,the investigators intent to explore the predictive and prognostic biomarker, as well as the changes in immune repertoire.

NCT ID: NCT03242538 Completed - Pelvic Cancer Clinical Trials

Prehabilitation for Pelvic Cancer: Changes in Setup Variability

Start date: June 23, 2017
Phase: N/A
Study type: Interventional

The investigators hypothesize that two pelvic relaxation exercises will be feasible and safe to perform by subjects daily before radiation during the participant's treatment and will decrease variability of sacral slope measurements on daily port films. The investigators will observe trends in the daily variability and change in the sacral slope in each participant to determine if this could decrease variability. The investigators will compare these measurements to a retrospective cohort that did not have the exercises, but did demonstrate variability. Reducing set-up variability (which inadvertently occurs during radiation) is important to improve radiation targets and diminish potential adverse effects. The investigators will query participants for objective and subjective feedback on the exercises and record frequency and duration of the two exercises.

NCT ID: NCT00647569 Completed - Incisional Hernia Clinical Trials

Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer

VRAM
Start date: April 2008
Phase: Phase 3
Study type: Interventional

The aim of the present project is to investigate whether use of biological mesh at the donor site of the rotation flap in closure of the abdominal wall reduce the frequency of incisional hernia formation compared to the usual abdominal wall closure after abdominal rotation flap operation in surgery for advanced pelvic cancer.

NCT ID: NCT00455351 Completed - Radiotherapy Clinical Trials

Vorinostat and Palliative Radiotherapy

PRAVO
Start date: February 2007
Phase: Phase 1
Study type: Interventional

Phase I study. Side-effects when combined with standard palliative radiotherapy.